Sharon Bio-Medicine Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹3.3Prev. Close
₹3.45Turnover(Lac.)
₹0.29Day's High
₹3.3Day's Low
₹3.352 Week's High
₹052 Week's Low
₹0Book Value
₹9.6Face Value
₹2Mkt Cap (₹ Cr.)
39.25P/E
1.01EPS
3.19Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2016 |
|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 37.51 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 90.38 | 48.83 | 25.14 | -219 |
Net Worth | 90.39 | 48.84 | 25.15 | -181.49 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2016 | Jun-2015 | Jun-2014 | Jun-2013 |
|---|---|---|---|---|
Revenue | 253.45 | 833.95 | 1,313.76 | 1,059.49 |
yoy growth (%) | -69.6 | -36.52 | 23.99 | 34.95 |
Raw materials | -332.25 | -808.49 | -1,112.74 | -902.07 |
As % of sales | 131.08 | 96.94 | 84.69 | 85.14 |
Employee costs | -16.54 | -19.82 | -18.87 | -14.31 |
| Y/e 31 Mar( In .Cr) | Mar-2016 | Jun-2015 | Jun-2014 | Jun-2013 |
|---|---|---|---|---|
Profit before tax | -217.88 | -144.56 | 84.75 | 66.18 |
Depreciation | -15.01 | -19.16 | -15.35 | -12.12 |
Tax paid | -9.96 | -4.66 | -15.13 | -13.33 |
Working capital | -262.07 | -118.82 | 152.7 | 135.55 |
Other operating items |
| Y/e 31 Mar | Mar-2016 | Jun-2015 | Jun-2014 | Jun-2013 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -69.6 | -36.52 | 23.99 | 34.95 |
Op profit growth | 289.25 | -121.89 | 30.35 | 26.46 |
EBIT growth | 188.51 | -135.51 | 31.24 | 25.08 |
Net profit growth | 32.47 | -424.43 | 31.7 | 27.02 |
| Particulars (Rupees in Crores.) | Mar-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|---|
Gross Sales | 253.45 | 838.46 | 1,324.79 | 1,073.52 | 804.14 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 253.45 | 838.46 | 1,324.79 | 1,073.52 | 804.14 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.95 | 2.63 | 1.92 | 1.19 | 1.24 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,838.3 | 146.85 | 4,40,793.82 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,743 | 67.22 | 1,78,956.35 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,429.8 | 67.72 | 1,49,819.64 | 467 | 0.86 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,351.8 | 31.77 | 1,09,370.14 | 384.64 | 0.96 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,070.8 | 29.18 | 1,07,757.6 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Savita Gowda
Whole-time Director
Lalit Misra
Director
Nivedita Patil
Director
Harish Palecanda
W-34 34/1 MIDC,
Taloja,
Maharashtra - 410208
Tel: -
Website: http://www.sharonbio.com
Email: investor_complaints@sharonbio.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Incorporated in 1989,Sharon Bio-Medicine Ltd is engaged in the pharmaceuticals/chemicals segment.The company had developed a number of products in active pharmaceutical ingredient (API), intermediates...
Read More
Reports by Sharon Bio-Medicine Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.